FDA Clearance Tracker · DEN180059
Nerivio Migra
Last checked: Nov 20, 2026Latest source record: May 20, 2019 (this decision)Source: openFDAMethods & limitations
Decided
May 20, 2019
De Novo granted
Time to decision
195 days
Received Nov 6, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class II
The decision
- FDA number
- DEN180059
- Device name
- Nerivio Migra
- Applicant
- Theranica Bioelectronics , Ltd.
- Applicant location
- Netanya, IL
- Received
- Nov 6, 2018
- Decided
- May 20, 2019
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device class
- Class II
- Regulation
- 21 CFR 882.5899
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for DEN180059
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Theranica Bioelectronics , Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- NerivioInfinity510(k)
K232152 · Decided Nov 8, 2023 · 112 days after receipt
Device type: Distal Transcutaneous Electrical Stimulator For Treatment Of Acute Migraine (QGT) · Neurology & Neurosurgery
- Nerivio510(k)
K223169 · Decided Feb 6, 2023 · 118 days after receipt
Device type: Distal Transcutaneous Electrical Stimulator For Treatment Of Acute Migraine (QGT) · Neurology & Neurosurgery
- Nerivio, FGD000075-4.7510(k)
K203181 · Decided Jan 22, 2021 · 88 days after receipt
Device type: Distal Transcutaneous Electrical Stimulator For Treatment Of Acute Migraine (QGT) · Neurology & Neurosurgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.